Trial Profile
Preoperative (neoadjuvant) or postoperative (adjuvant) therapy of patients with stages IB, II, IIIA non-small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2013
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 22 Oct 2005 New trial record.